Turning regenerative medicine from research into reliable production
Most breakthroughs in regenerative medicine never reach patients because they can't be produced at scale. Manual lab processes don't translate easily into consistent, industrial manufacturing, and that's where we come in.
At ReGEN Biomedical, we help partners bridge that gap. We combine cell biology, automation, bioprinting, and engineering under one roof, so you can move from a working protocol to a scalable, reproducible process, and ultimately, to clinical and commercial reality.
What we offer
We work with partners in three complementary ways. Whether you need tissue production as a proof-of-principle, an existing protocol made scalable, or custom equipment built from the ground up, we can support you across the full path from lab to manufacturing.
Our areas of expertise
Across these three offerings, our team brings hands-on experience in a broad range of cell biology, tissue engineering and automation techniques. Behind every capability listed below is an expert who's spent years working with it, meet the people who bring this expertise to your project.
We've grouped our capabilities into five categories below. Click on any category to see the specific techniques and platforms we work with.
-
hMSC expansion in small-scale stirred tank bioreactors
-
hMSC and chondrocyte expansion in plates
-
iPSC expansion in Vertical Wheel bioreactor
-
iPSC expansion in plates
-
SCINUS expansion: adherent cultures using microcarriers
-
SCINUS expansion: suspension cultures
-
Chondrocyte expansion on microcarriers
-
Static and dynamic microcarrier-based cultures in well plates
Don't see exactly what you need? Many of our techniques can be adapted, combined or extended for new applications.
Our facility & quality approach
Quality is built into how we design and run our operations, not bolted on at the end.
A facility built for the work
Our laboratories are designed to support high-quality cell culture and advanced therapy development. The setup includes classified cleanroom environments and controlled laboratory spaces, with continuous environmental monitoring of particulates, temperature, humidity and pressure. This allows us to maintain controlled conditions and proactively manage contamination risks.
A quality system that scales with you
Our Quality Management System (QMS) is being developed to ensure that all activities are performed in a controlled, traceable, and risk-based way. It integrates the processes you'd expect of a partner working toward clinical and commercial readiness, including Deviation Management, CAPA, Change Control, and Risk Management. Together, these support both our current R&D activities and the future transition to regulatory-compliant operations.
​
A clear pathway to GMP
While we currently operate in an R&D setting, our quality approach is guided by established industry standards, including GMP principles and ISO-based practices. Our facility is GMP-upgradeable, and our systems are designed to support a clear pathway toward regulatory-aligned development when our partners need it, whether that's early-stage development today or clinical and commercial production tomorrow.
​
How we work with partners
Every regenerative medicine project is different, so we adapt how we engage based on what you need. Most of our collaborations fall into one of three models:
